Saúde e estilo de vida prévios à COVID-19 de pacientes que desenvolveram quadros graves e estiveram internados no Tocantins

Authors

  • Tatiana Vieira Ferreira
  • Araída Dias Pereira
  • Antonio Hélio Vieira
  • Sandra Maria Botelho Mariano
  • Renata Junqueira Pereira

DOI:

https://doi.org/10.54033/cadpedv21n1-138

Keywords:

hospitalização, determinantes sociais de saúde, SARS-CoV-2

Abstract

As primeiras infecções por SARS-CoV-2 foram identificadas no final de 2019, apresentando uma alta taxa de contaminação e representando grandes desafios aos sistemas de saúde globais. Esse estudo, do tipo transversal retrospectivo, foi realizado no Tocantins, com 113 sobreviventes à internação pela Covid-19 grave, submetidos à hospitalização entre abril e setembro de 2020. Buscou-se descrever os perfis sociodemográfico, de saúde e de estilo de vida pré-infecção. A maioria dos sobreviventes era do sexo masculino, de idade mediana igual a 56 anos, autodeclarados pardos, com média escolaridade e renda básica. A maioria não era tabagista ou etilista, mas relatou dificuldades para dormir e pouca ou nenhuma prática de atividades físicas. Considerando as características clínicas, 90,3% dos pacientes relataram a presença de comorbidades preexistentes, sendo a hipertensão arterial sistêmica (54,0%) e a  dislipidemia (33,6%) as mais prevalentes. Devido às condições de saúde prévias, os medicamentos mais utilizados foram anti-hipertensivos (51,3%) e estatinas (16,8%). O perfil da população estudada sugere que  a idade avançada, ser do sexo masculino, possuir baixa escolaridade e baixa renda, fazer uso de fumo e de álcool, a inatividade física e a presença de comorbidades podem ter sido fatores de suscetibilidade, relacionados à gravidade e ao tempo de internação pela Covid-19.

References

BACELAR, A. et al. Sintomas de insônia durante a pandemia de covid-19: um estudo caso-controle. Revista de Saúde Pública, v. 57, p. 8, 2023. DOI: https://doi.org/10.11606/s1518-8787.2023057004801

BRASIL. Ministério da Saúde. COVID-19 no Brasil: Dados. Brasil: Secretarias Estaduais de Saúde, 2023. Disponível em: <https://infoms.saude.gov.br/

extensions/covid-19_html/covid-19_html.html>. Acesso em 10 nov. 2023.

BISHOP, C. W. et al. REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients. Nutrition, v. 107, p. 111899, 2023 DOI: https://doi.org/10.1016/j.nut.2022.111899

CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) – United States, February 12 – March 16, 2020. CDC, v. 69, p. 343-346, 2023. DOI: https://doi.org/10.15585/mmwr.mm6912e2

CHEN, X. et al. Causal relationship between physical activity, leisure sedentary behaviors and COVID-19 risk: a Mendelian randomization study. Journal of Translational Medicine, v. 20, n. 1, p. 1-12, 2022. DOI: https://doi.org/10.1186/s12967-022-03407-6

DE ABAJO, F. J. et al. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet, v. 395, p. 1705-1714, 2020.

DESIDERIO, V. L. et al. Variáveis associadas ao desfecho clínico de pacientes hospitalizados por COVID-19. Revista de Medicina, v. 100, n. 5, p. 431-441, 2021. DOI: https://doi.org/10.11606/issn.1679-9836.v100i5p431-441

DE SOUZA, F. R. et al. Association of physical activity levels and the prevalence of COVID-19-associated hospitalization. Journal of science and medicine in sport, v. 24, n. 9, p. 913-918, 2021. DOI: https://doi.org/10.1016/j.jsams.2021.05.011

ECONOMIC COMMISSION FOR LATIN AMERICA AND THE CARIBBEAN (ECLAC). The impact of COVID-19 on indigenous peoples in Latin America (Abya Yala): between invisibility and collective resistance. ECLAC, Santiago, 2021.

FEINGOLD, K. R. Lipid and lipoprotein levels in patients with COVID-19 infecctions. Endotext Internet, 2022. Disponível em: <https://www.endotext.

org/registration/?_s2member_vars=post..level..0..post..11981..L2NoYXB0ZXIvbGlwaWQtYW5kLWxpcG9wcm90ZWluLWxldmVscy1pbi1wYXRpZW50cy13aXRoLWNvdmlkLTE5LWluZmVjdGlvbnMv&_s2member_sig=1700403752-e7006b6b0418831fe2bb75768ff67d59>. Acesso em: 7 nov. 2023.

FERREIRA, J. C. et al. Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome. Journal of Global Health, v. 12, 2022. Disponível em: <https://www-ncbi-nlm-nih.ez6.periodicos.capes.gov.br/pmc/arti

cles/PMC9359428/>. Acesso em: 11 nov. 2023.

FIGLIOZZI, S. et al. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. European Journal of Clinical Investigation, v. 50, p. 1-15, 2020. DOI: https://doi.org/10.1111/eci.13362

GOLD, M. S et al. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgraduate Medicine, p. 1-7, 2020. DOI: https://doi.org/10.1080/00325481.2020.1786964

GUPTA, A. et al. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nature communications, v. 12, p. 1325, 2021. DOI: https://doi.org/10.1038/s41467-021-21553-1

INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA (IBGE). PNAD contínua: Rendimento de todas as fontes 2021. IBGE: Pesquisa Nacional por Amostra de Domicílios Contínua, 2022. Disponível em: <https://www.paho.org/

pt/documentos/hoja-informativa-alcohol-covid-19-lo-que-debe-saber>. Acesso em: 10 nov. 2023.

KAKODKAR, P., KAKÁ. N., BAIG, M. N. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus, v. 12, n. 4, p. 7560, 2020. DOI: https://doi.org/10.7759/cureus.7560

LEE, S. W. et al. Physical activity and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 related mortality in South Korea: a nationwide cohort study. British Journal of Sports Medicine, v. 56, n. 16, p. 901-912, 2022. DOI: https://doi.org/10.1136/bjsports-2021-104203

LESCURE, F. X. et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. The Lancet Infectious Diseases, v. 20, n. 6, p. 697-706, 2020. DOI: https://doi.org/10.1016/S1473-3099(20)30200-0

LI, S. L. et al. Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil. BMJ Global Health, v. 6, n. 4, p. e004959, 2021. DOI: https://doi.org/10.1136/bmjgh-2021-004959

LI, D. et al. Association of physical activity and the risk of COVID-19 hospitalization: A dose–response meta-analysis. Medicine, v. 102, n. 4, 2023. DOI: https://doi.org/10.1097/MD.0000000000032814

MORAVIESKI, A. C. et al. Vitamina de covid-19: uma revisão sistemática. Arquivos de Ciências da Saúde da UNIPAR, v. 27, n. 9, p. 5401-5422, 2023. DOI: https://doi.org/10.25110/arqsaude.v27i9.2023-032

OECD/THE WORLD BANK. Panorama da Saúde: América Latina e Caribe 2023. OECD Publishing, Paris, 2023.

ORGANIZACIÓN PANAMERICANA DE LA SALUD (OPAS). División de Promoción y Protección de la Salud (HPP). Encuesta Multicentrica salud beinestar y envejecimiento (SABE) em América Latina el Caribe: Informe Preliminar [Internet]. Kingston, Jamaica: OPAS, 2002. Disponível em: www.opas.org/program/sabe.htm. Acesso em: 15 nov. 2023.

PENG, L. et al. Insomnia and sleep duration on COVID-19 susceptibility and hospitalization: A Mendelian randomization study. Frontiers in Public Health, v. 10, p. 995664, 2022. DOI: https://doi.org/10.3389/fpubh.2022.995664

RAZA, S. A. et al. Predictors of COVID-19 perceived susceptibility: insights from population-based self-reported survey during lockdown in the United States. Journal of Infection and Public Health, v. 15, n. 5, p. 508-514, 2022. DOI: https://doi.org/10.1016/j.jiph.2022.03.012

SOCIEDADE BRASILEIRA DE DERMATOLOGIA (SBD). SBD alerta: faltam evidências científicas sobre a prevenção à COVID-19 por meio de exposição ao sol ou consumo indiscriminado de vitamina D. SBD, 2021.

THAI, P. Q. et al. Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: a survival analysis. Epidemiology and Infeccion, v. 148, p. 114, 2020. DOI: https://doi.org/10.1017/S0950268820001259

VARDAVAS, C. I.; NIKITARA, K. COVID-19 and smoking: A systematic review of the evidence. Tobacco induced diseases, v. 18, 2020. DOI: https://doi.org/10.18332/tid/119324

VILLATORO, J. M. et al. A cases-control of patients with COVID-19 to explore the association of previous hospitalisation use of medication on the mortality of COVID-19 disease: a propensity score matching analysis. Pharmaceuticals, v. 15, n. 1, p. 78, 2022. DOI: https://doi.org/10.3390/ph15010078

WANG, Y. et al. Association of insomnia disorder with sociodemographic factors and poor mental health in COVID-19 inpatients in China. Sleep Medicine, v. 75, p. 282-286, 2020. DOI: https://doi.org/10.1016/j.sleep.2020.06.011

WISE, J. A third of covid-19 patients admitted to UK hospitals die. The BMJ, v. 369, p. 1794, 2020. DOI: https://doi.org/10.1136/bmj.m1794

WORLD HEALTH ORGANIZATION (WHO). The use and interpretation of antropometry physical status: the use and interpretation of anthropometry. Report of a Who Expert Commitee Switzerland: WHO; 1995.

WORLD HEALTH ORGANIZATION (WHO). O álcool e a COVID-19: o que você precisa saber. WHO, 2020. Disponível em: <https://www.paho.org/pt/documen

tos/hoja-informativa-alcohol-covid-19-lo-que-debe-saber>. Acesso em: 7 nov. 2023.

YONG, S. J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases, v. 53, n. 10, 737-754, 2021 DOI: https://doi.org/10.1080/23744235.2021.1924397

Published

2024-01-26

How to Cite

Ferreira, T. V., Pereira, A. D., Vieira, A. H., Mariano, S. M. B., & Pereira, R. J. (2024). Saúde e estilo de vida prévios à COVID-19 de pacientes que desenvolveram quadros graves e estiveram internados no Tocantins. Caderno Pedagógico, 21(1), 2558–2574. https://doi.org/10.54033/cadpedv21n1-138

Issue

Section

Articles